Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-08

Clinical Trial Update: Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for oral nitazoxanide in acute gastroenteritis in Australian Indigenous children; study phases 2 and 3 have been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Telethon Kids Institute | Conditions: Gastroenteritis | Phase 2, Phase 3 | Status: TERMINATED